HOME >> MEDICINE >> NEWS
Exploring better ways to determine when to change the course of treatment

Counting circulating tumor cells before and after the start of treatment for patients with metastatic colorectal cancer could help doctors determine when or if a change in treatment should be made. The results of a large, multicenter, international study laying the groundwork for such decisions were presented today at the Annual Meeting of the American Society of Clinical Oncology. The study showed the number of circulating tumor cells, or CTC, is a significant predictor of survival and cancer progression.

Few studies have examined the relationship of CTC and a patient's prognosis in cancer. This is an important area of research in metastatic colorectal cancer because there are little data to help physicians chose which treatment is best for which patients or to determine when a change in treatment is warranted.

"If we had a way to know early on that a tumor isn't responding to a particular drug, we could switch to a different treatment before growth of the cancer is seen on a CAT scan," said Neal J. Meropol, director of the gastrointestinal cancer program at Fox Chase Cancer Center and lead investigator of the study. "If we could determine that the tumor was destined to grow after a few weeks of treatment, we'd be able alter course even before the first scan."

For this study, Meropol and his colleagues examined the association between the circulating tumor cell number and progression-free and overall survival for 430 adult patients with metastatic colorectal cancer.

The number of CTC was measured at baseline, one month, and several other points after the start of treatment. CTC were isolated and counted by an immunomagnetic cell separation technique, an FDA-approved technology developed by Immunicon Corporation (Nasdaq-Global Market: IMMC}. CT scans were obtained in usual practiceat baseline and every 6-12 weeks after starting treatment.

Having 3 or more CTC (per 7.5 mL of blood) was defined as "unfavo
'"/>

Contact: Karen Mallet
karen.mallet@fccc.edu
215-728-9751
Fox Chase Cancer Center
3-Jun-2007


Page: 1 2

Related medicine news :

1. Exploring the molecular origin of blood clot flexibility
2. Exploring the potential of cholesterol-lowering drugs for patients with systemic sclerosis
3. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
4. Waist-to-hip ratio may better predict cardiovascular risk than body mass index
5. Warfarin better than aspirin at stroke prevention in elderly people with atrial fibrillation
6. Nonsmall cell lung cancer -- chemotherapy before surgery appears better than surgery alone
7. Stroke in nonvascular atrial fibrillation -- anti-coagulants better than anti-platelet therapy
8. Holograms make for better vision tests
9. Parents of chronically ill kids are helped by better access to federal and employer leave
10. Diabetes professionals join forces to identify gaps in diabetes care and better self care
11. Gene variations point to why lung cancer drugs work better in Japanese vs. US patients

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Exploring better ways determine when change the course treatment

(Date:4/28/2015)... 28, 2015 An Allegheny Health ... Jobe, MD, FACS , has launched the first U.S. ... extracellular matrix (ECM) can help patients who are at ... cancer. , ECM is a complex mixture of naturally-occurring ... migration and signals that guide cell behavior. ECM, manufactured ...
(Date:4/28/2015)... Georgia Partnership for TeleHealth ... programs in communities throughout Georgia, announces that four members ... at the American Telemedicine Association ’s ATA 2015 ... Angeles, CA. , GPT’s roster of conference speakers ... Director; Loren Nix, Liaison; and board member Dr. Jean ...
(Date:4/28/2015)... Hellen Chen, who is a bestselling author ... According to a study conducted by Washington University, ... 30 has increased by 20% while the number of unfaithful ... a report released this year from the Journal ... one or both spouses admit to infidelity, either physical or ...
(Date:4/28/2015)... Colorado (PRWEB) April 28, 2015 Colorado ... an updated version of his popular spine education website ... ASKSPINEDOC.COM developed by eMedical Media. This website has ... of the anatomy of the spine, causes of neck ... Dr. Corenman created this website and personally answers questions ...
(Date:4/28/2015)... (PRWEB) April 28, 2015 SeniorCare.com has ... delves into the reality problem Americans have regarding aging ... will need long-term care services as they age, 63% ... care. , In the report, Carol Marak of ... as the American Health Care Association and The Scan ...
Breaking Medicine News(10 mins):Health News:Allegheny Health Network Launches First U.S. Clinical Trial of Extracellular Matrix as Replacement for Pre-Cancerous Tissue 2Health News:Allegheny Health Network Launches First U.S. Clinical Trial of Extracellular Matrix as Replacement for Pre-Cancerous Tissue 3Health News:Georgia Partnership for TeleHealth Team Selected to Present at ATA 2015 2Health News:Why Do Some Good Women and Men End Up Breaking Others' Marriages? 2Health News:Why Do Some Good Women and Men End Up Breaking Others' Marriages? 3Health News:Colorado Spine Surgeon Donald Corenman, MD, DC Launches Updated Version of NECKANDBACK.COM and Popular Back Pain Forum ASKSPINEDOC.COM 2Health News:Colorado Spine Surgeon Donald Corenman, MD, DC Launches Updated Version of NECKANDBACK.COM and Popular Back Pain Forum ASKSPINEDOC.COM 3Health News:SeniorCare.com Report: America Has a Major Misconception on Aging 2
(Date:4/28/2015)... OTTAWA , April 28, 2015 /CNW/ - The group ... worst-ever drug tragedy left a two-hour meeting with ... concern. On March 6th, Health Canada announced a $180 ... 27, more than six weeks after the Health Canada ... Parliament to fully support the victims, the group representing ...
(Date:4/28/2015)... , April 28, 2015  Shares of Celladon Corp. ... value yesterday following the announcement of poor drug trial results ... cardiovascular gene therapy agent, MYDICAR.  The selloff may be ... a company at bargain basement prices. An ... company overview, current pipeline, financial review, analyst summary, valuation, ...
(Date:4/28/2015)... , April 28, 2015 We are living ... our gateway to the world and very soon we will ... locks and car. The connected life market has been valued ... but are companies prepared to drive and manage this change ... we live?  Highlights of the congress include ...
Breaking Medicine Technology:Thalidomide Victims Gravely Concerned by Health Canada's Silence 2Examining what's Left after MYDICAR Drug Trial Ends In Failure; Celladon Corp. Analyst Report Issued by BrokerBank Securities, Inc. 2Frost & Sullivan's GIL 2015 Unveils the $700 Billion Connected Life Market 2Frost & Sullivan's GIL 2015 Unveils the $700 Billion Connected Life Market 3
Cached News: